Merck

Merck KGaA shares data justifying pushing lupus drug into phase 3—despite recent setback
Fierce Biotech
Wed, 05/21/25 - 10:21 pm
Merck
KGaA
lupus
clinical trials
enpatoran
Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain recurrent patients
Fierce Pharma
Thu, 05/15/25 - 10:25 pm
Merck
Keytruda
ovarian cancer
clinical trials
Merck begins construction on $1B Keytruda manufacturing facility in Delaware
Fierce Pharma
Wed, 04/30/25 - 10:54 am
Merck
Delaware
Keytruda
drug manufacturing
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
BioSpace
Mon, 04/28/25 - 09:38 am
AACR
Merck
Keytruda
head and neck cancer
Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through
Fierce Pharma
Thu, 04/24/25 - 09:17 pm
Halozyme
Merck
Keytruda
patents
legal
Merck lowers profit outlook, partly due to $200 million expected tariff hit
CNBC
Thu, 04/24/25 - 10:51 am
Merck
earnings
tariffs
Trodelvy-Keytruda combo improves cancer trial outcomes
Investing.com
Mon, 04/21/25 - 11:11 am
Gilead Sciences
Trodelvy
Keytruda
Merck
metastatic triple-negative breast cancer
Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides
Fierce Biotech
Tue, 04/15/25 - 07:40 pm
Merck
biobucks
Cyprumed
drug delivery
peptides
The 5 largest biopharma layoffs of Q1 2025
BioSpace
Fri, 04/11/25 - 11:47 am
layoffs
Novartis
Galapagos
Bristol Myers Squibb
Merck
Gilead Sciences
Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers
Fierce Pharma
Thu, 04/10/25 - 10:04 pm
Merck
Rob Davis
Pharma CEOs
executive compensation
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
Merck's Winrevair slashes mortality-morbidity risk by 76%
Fierce Pharma
Mon, 03/31/25 - 11:02 am
Merck
PAH
Winrevair
clinical trials
Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme
Fierce Pharma
Thu, 03/27/25 - 11:39 am
Merck
Keytruda
non-small cell lung cancer
Merck & Co. pens $200M upfront deal for Hengrui's midstage heart disease med
Fierce Biotech
Tue, 03/25/25 - 11:23 am
Merck
Hengrui Pharma
HRS-5346
lipoprotein(a)
heart disease
Merck to push for approval of HIV combo after Phase III success
Clinical Trials Arena
Thu, 03/13/25 - 11:31 am
Merck
HIV
clinical trials
Pifeltro
islatravir
Merck prevails in US safety litigation over Gardasil HPV vaccine
Investing.com
Tue, 03/11/25 - 07:02 pm
Merck
Gardasil
vaccines
HPV
cervical cancer
legal
Merck Opens Vaccine Manufacturing Facility in North Carolina
US News and World Report
Tue, 03/11/25 - 11:14 am
Merck
vaccines
North Carolina
drug manufacturing
tariffs
Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck
MSN/Bloomberg
Wed, 03/5/25 - 11:26 pm
Moderna Therapeutics
Merck
cancer
vaccines
cancer vaccine
clinical trials
CDC report adds to evidence that HPV vaccine is preventing cervical cancer in US women
MSN
Thu, 02/27/25 - 09:24 pm
vaccines
CDC
cervical cancer
HPV
Gardasil
Merck
Cervarix
GSK

Pages